Camrelizumab Combined With Albumin-bound Paclitaxel and Platinum in Neoadjuvant Treatment of Resectable NSCLC

NCT04338620 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

94

Enrollment

OTHER

Sponsor class

Conditions

Non-small-cell Lung Cancer (NSCLC)

Interventions

DRUG: camrelizumab、albumin-bound paclitaxel and platinum
DRUG: albumin-bound paclitaxel and platinum

Sponsor

Tang-Du Hospital